Literature DB >> 31327237

Changes in the Serum Metabolome of Acute Myocardial Ischemia Rat Pretreatment with Electroacupuncture.

Hong-Ru Zhang1, Jia-Lei Tao2, Hua Bai1, Eun-Mee Yang1, Ze-Hao Zhong1, Xin-Tong Liu1, Yi-Huang Gu1, Sheng-Feng Lu1,3.   

Abstract

Myocardial infarction (MI), the most common symptom is chest pain, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. Electroacupuncture pretreatment (EP) is a recent observation which has been shown to induce ischemic tolerance like the ischemia preconditioning, suggesting that EP may be a promising preventive strategy for individual susceptibility to MI. This study investigated mechanisms that underlie the effect of EP on MI through the use of gas chromatography-mass spectrometry (GC-MS)-based metabolic profiling. Male Sprague-Dawley rats were randomly divided to receive or not receive three days of EP at PC6 (Neiguan). Then on the fourth day, each group was further divided to undergo mock surgery or MI, induced by ligation of the left anterior descending coronary artery. After 24h, the blood samples and hearts were collected for the follow-up research. The results showed that treatment by EP significantly reduced the levels of CK-MB, cTnT, AST, and MDH in serum and decreased myocardial infarction area. According to GC-MS-based serum metabolic profiling and analysis, a total of 636 characteristic peaks were identified, including 158 known and 478 unknown metabolites. MI caused comprehensive metabolic changes in glycolysis-related metabolites, malate-aspartate shuttle (MAS) metabolites, and purine metabolites with anti-oxidant functions, while EP reversed more than half of the differential metabolic changes, mainly affecting amino acid and energy metabolism, especially the glutamate metabolism and MAS. In a word, our findings suggest that EP exerts its cardioprotective effect on MI by regulating amino acid and energy metabolisms. Meanwhile, GC-MS-based metabolomics provided a powerful way to characterize the metabolic features of MI, with and without EP, and thereby improved our understanding of the effect and mechanisms of EP.

Entities:  

Keywords:  Electroacupuncture Preconditioning; GC-MS; Malate-Aspartate Shuttle; Metabolomics; Myocardial Infarction Injury

Mesh:

Year:  2019        PMID: 31327237     DOI: 10.1142/S0192415X19500526

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  5 in total

1.  Acupuncture as an adjunctive therapy for arrhythmia: a Delphi expert consensus survey.

Authors:  Jin-Ling Li; Li-Qiong Wang; Na Zhang; Xin-Tong Su; Ying Lin; Jing-Wen Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Cardiovasc Diagn Ther       Date:  2021-10

2.  Electroacupuncture Improves Choroidal Blood Flow to Inhibit the Development of Lens-Induced Myopia in Guinea Pigs.

Authors:  Ting Yu; Xiaofeng Xie; Huixia Wei; Qiuxin Wu; Xiuyan Zhang; Qingmei Tian; Jike Song; Hongsheng Bi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-24       Impact factor: 2.650

3.  Effect of Electroacupuncture at Wushu Acupoints of the Cardiopulmonary Meridian on the Autophagy in Rats with Acute Myocardial Ischemia.

Authors:  Chao Zhu; Shengbing Wu; Xin Wu; Meiqi Zhou; Kun Wang; Shuai Cui; Jie Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

4.  Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism.

Authors:  Xiaoying Ling; Jie Zhou; Tianzi Jin; Weichen Xu; Xun Sun; Weifeng Li; Yali Ding; Miaomiao Liang; Chenbi Zhu; Peipei Zhao; Chanchan Hu; Bin Yuan; Tong Xie; Jialei Tao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

5.  Full-length transcriptome analysis reveals the mechanism of acupuncture at PC6 improves cardiac function in myocardial ischemia model.

Authors:  Jing Yuan; Jun-Meng Wang; Zhi-Wei Li; Cheng-Shun Zhang; Bin Cheng; Su-Hao Yang; Bai-Tong Liu; Li-Juan Zhu; Ding-Jun Cai; Shu-Guang Yu
Journal:  Chin Med       Date:  2021-07-08       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.